Although the results showed no difference in quantity of Fn between BRAF-mutant and non–BRAF-mutant colorectal cancer or between KRAS-mutant and non–KRAS-mutant colorectal cancer, the question of whether high loads of Fn were associated with BRAF or KRAS mutations was not determined (35). This evidence concerns the gene KRAS and colorectal cancer.